Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
506.00    4.00 (0.80%)
Bid:
502.00
Ask:
506.00
Spread: 4.00 (0.797%)
Market Cap: £833.71m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Results analysis from Kepler Trust Intelligence

12 Mar 2020 07:33

RNS Number : 8965F
Oakley Capital Investments Limited
12 March 2020
 

Oakley Capital Investments (OCI)

Results for financial year ended 31 December 2019

 

Results analysis from Kepler Trust Intelligence

Oakley Capital Investments (OCI) announced its results today, in which it reported a NAV total return of 25% over the twelve months to 31st December 2019. Over the same period, the discount narrowed such that shareholder returns (including price increase and dividend) were 56%.

 

Illustrating the conservatism that had been built into valuations, realisations that were agreed during 2019 were at a combined 97% premium to the prevailing book value (average premium to book on realisations since inception is 34%). Whilst this clearly represents an exceptional year for Oakley Capital, it demonstrates that their focussed approach delivers impressive NAV growth.

 

CLICK HERE TO READ THE FULL REPORT

 

Disclaimer

This report has been issued by Kepler Partners LLP. The writer who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only. 

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

 

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAGRGDXCDBDGGD
Date   Source Headline
11th Sep 20257:00 amRNSInterim Results for the 6 months ended 30 June 25
10th Sep 20257:00 amRNSResult of AGM - Replacement
2nd Sep 20252:20 pmRNSResult of AGM
1st Sep 20257:00 amRNSTotal Voting Rights
28th Aug 202512:45 pmRNS-RQuotedData's In The HotSeat Special
28th Aug 20257:00 amRNSNotice of Results and Investor Presentation
21st Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSDirector Dealing
7th Aug 20257:00 amRNSNotice of Annual General Meeting
4th Aug 20257:00 amRNSOakley granted exclusivity to invest in Brevo
1st Aug 20259:06 amRNSConfirmation of Admission to New Listing Category
1st Aug 20257:00 amRNSTotal Voting Rights
30th Jul 20257:03 amRNSTransaction in Own Shares
30th Jul 20257:01 amRNSNew Listing Category
30th Jul 20257:00 amRNSTrading Update for the 6 Months ended 30 June 2025
29th Jul 20257:00 amRNSTransaction in Own Shares
18th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
2nd Jul 20257:00 amRNSTotal Voting Rights
1st Jul 20257:00 amRNSOakley expands portfolio of heritage brands
30th Jun 20251:42 pmRNSOakley Capital agrees sale of vLex to Clio
24th Jun 20257:00 amRNSTransaction in Own Shares
11th Jun 20257:00 amRNSOakley Capital invests in G3
11th Jun 20257:00 amRNSOakley Capital invests in JBMC
9th Jun 20257:00 amRNSTransaction in Own Shares
4th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSOakley Capital invests in Infravadis
3rd Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 20257:00 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNSTransaction in Own Shares
16th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSTransaction in Own Shares
13th May 20257:00 amRNSTransaction in Own Shares
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSTransaction in Own Shares
7th May 20257:00 amRNSTransaction in Own Shares
6th May 20257:00 amRNSTransaction in Own Shares
2nd May 20257:00 amRNSTransaction in Own Shares
1st May 20257:00 amRNSTotal Voting Rights
1st May 20257:00 amRNSTransaction in Own Shares
30th Apr 20257:00 amRNSTrading update for the 3 months ended 31 March 25

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.